©2022 Australasian Society of Clinical Immunology and Allergy (ASCIA)
ABN 45 615 521 452


ASCIA Reports and Submissions


ASCIA Submissions 2020-2022 | ASCIA Submissions 2019 | ASCIA Annual Highlights, Annual Reports, AGM Minutes, Financial Reports | ASCIA Scope of Practice documentsNational Allergy Strategy  | ASCIA/NPS Choosing Wisely Australia and RACP Evolve recommendations  | Allergy in Australia 2014 | Allergy and Immune Diseases in Australia (AIDA) Report 2013 | ASCIA Education Resources Report 2013 | Economic Impact of Allergies Report 2007

ASCIA continues to advocate on behalf of ASCIA members to government and other organisations by lodging submissions which are listed below. 

ASCIA Submissions 2022

ASCIA Submissions 2021

ASCIA Submissions 2020

ASCIA Submissions 2019

ASCIA Annual Highlights, Annual Reports, AGM Minutes, Financial Reports

Summaries of annual highlights

ASCIA Annual General Meeting (AGM) Minutes

ASCIA Annual Reports

ASCIA Financial Reports are available on the Australian Charities and Not-for-profits Commission (ACNC) website (ASCIA is a Company limited by guarantee (ACN 608 798 241; ABN 45 615 521 452) and is registered with the ACNC.

ASCIA Scope of Practice documents

Scope of Practice - Allergy Skin Testing in Australia 2018

ASCIA developed this Scope of Practice  in response to the Medicare Benefits Schedule (MBS) item number changes implemented by the MBS Review Taskforce, effective 1 November 2018.  Whilst these changes were not initiated by ASCIA, the previously proposed item numbers were significantly modified in response to a submission made by ASCIA in July 2017, to ensure patients with complex allergic disease are not disadvantaged.

pdfASCIA Scope of Practice - Allergy Skin Testing in Australia 2018171.23 KB

Scope of Practice - Specialist Physicians in Immunology and Allergy in  Australia 2014

The aim of this Scope of Practice is to outline the range of practice of clinical immunology/allergy specialists in Australia and ensure that patients with allergic and other immune diseases receive the highest standard of care, in line with best clinical practice. 

pdfASCIA Scope of Practice Australia July 2014208.16 KB 

National Allergy Strategy

In 2021 ASCIA continues to contribute to, and promote the following National Allergy Strategy projects:

The National Allergy Strategy is a partnership between ASCIA and Allergy & Anaphylaxis Australia working in collaboration with other stakeholders. 

ASCIA Recommendations - NPS Choosing Wisely Australia and RACP Evolve 

choosing wiselyASCIA was the first Specialty Society affiliated with the Royal Australasian College of Physicians (RACP) to be involved in Choosing Wisely Australia, a health profession led initiative faciliated by National Prescribing Service (PBS) MedicineWise and the RACP Evolve program.  The ASCIA list of five things that clinicians and consumers should question is available at:

For further information about Choosing Wisely Australia go to  

 For further information about the RACP Evolve program go to

Allergy in Australia 2014

ASCIA Allergy in Australia 2014

Prior to ASCIA developing a National Allergy Strategy for Australia, the following report was developed in 2014. 

pdfAllergy in Australia 2014: A submission for allergic diseases to be recognised as a National Health Priority Area 606.54 KB


Allergy and Immune Diseases in Australia (AIDA) Report 2013

ascia aida report 2013The AIDA report on allergy and other immune diseases (immunodeficiency and autoimmune diseases) was developed in 2013.

pdfAllergy and Immune Diseases in Australia (AIDA) Report 2013720.33 KB  


ASCIA Education Resources Report 2013

ASCIA Education Resources ReportASCIA has been developing web based education resources since 1999. In 2013, the ASCIA Education Resouces Report was developed to outline the large range of web based educational resources that are all available at no charge on the ASCIA website.

pdfASCIA_Education_Report_July_2013483.57 KB   


Economic Impact of Allergies Report 2007

Economic Impact of AllergiesThe cost of allergies to the Australian economy is estimated to be $7.8 billion, with lost productivity and health system expenditure the major contributing factors. Furthermore, most Australians with allergies face a wait many months to see a specialist, if they can access care at all. These are among key findings in the following report 'Economic Impact of Allergies' by Access Economics that was released by ASCIA in November 2007. 

pdfEconomic Impact of Allergies Report - 20071.65 MB 


Content updated July 2022